Chulabhorn Royal College imported “Monocronal Antibody Cocktail” 4,000 doses.

Today (21 September 2021), Prof. Dr. Nithi Mahanon, Secretary-General of Chulabhorn Royal College said at the event, “Coping with the epidemic situationcorona virus 2019: antibody cocktail or immunosuppressive drugs” that vaccination is a way to make people in society confident. and able to return to a more normal life The Royal College of Chulabhorn Therefore, the vaccine has been brought to the people. And recently it has been injected for children. Because even if a child is infected with COVID-19 and the symptoms are not severe But there was an impact on education and social experience that was lost for 1 year at Chulabhorn Royal College. therefore trying to encourage children to be vaccinated

• “The Royal College of Chulabhorn” imported antibodies cocktails

“This disease will be with us for a long time. which when we have enough vaccines COVID is like the flu, but before that day The patient’s health care system must be properly managed. and need to educate the public The government requires that the Chulabhorn Royal College can provide vaccines and medication in an emergency Currently, monochronol antibody cocktails are imported to distribute to various hospitals. and joined with the hospital 2-3 sites to study new antiviral drugs, which are expected to be used soon.” Prof.Dr. Nithi say

However Chulabhorn Royal College It has prepared to import 4,000 doses of monochronol antibody cocktails to distribute to 50 hospitals, both public and private, that have registered to report the need for use. to cure covid due to its effective inhibition in the cellular system It is used to treat severely ill patients, the elderly, obesity, and chronic diseases. but as an alternative drug So there may be a cost. The preliminary that is imported is 1 dose, the price is 50,000 baht, of which 1 dose can be used by 1 person.

• “Monochronol” helps reduce symptoms of severe coronavirus

“To have more and more weapons to take care of COVID, there will be more and more vaccines, drugs, screening tests. and the body of knowledge that changes every day including virus mutations I want everyone to understand So that we can live with it, so when the information changes all the time. The thought process must change. Understand that everyone has to adjust to the thinking they have at different times. And let’s be confident that the evolution of medicine will be able to help everyone get back to their normal life.” Prof.Dr. Nithi say

Asst. Prof. Dr. Kamthorn Malatham, President of the Infectious Diseases Association of Thailand said the treatment of COVID-19 patients will use only various measures May not see clear results, must have many components and drug use is important. In the future, there may be many good antiviral drugs, such as monoclonal antibodies. Help treat patients who are at high risk of having to go to the ICU, such as the elderly with congenital disease. This is the group that requires the most resources and has the highest chance of dying. If used appropriately in a real risk group will reduce sickness and die

All over the world, there is a demand for monochronals. And very expensive is a limited access, but not everyone will get this drug. There must be a process of selecting patients for the best use of the drug.

• “Antibody Cocktail” antiviral drug to reduce loss

Assoc. Prof. Dr. Nithipat Jearakul, Head of the Department of Respiratory Disease and Tuberculosis Department of Internal Medicine Faculty of Medicine Siriraj Hospital Mahidol University Said that medical preparations were prepared at all times. Because it has to be taken care of properly. reduce the epidemic and preventing the spread of COVID-19, which now has a decrease in new cases what to donew patientDecrease gradually, not more and how to make new patients access treatment as quickly as possible and protect vulnerable groups Prevent him from using ventilators and intensive care severe, fatal

Asst. Prof. Opas Puttacharoen, Head of the Emerging Clinical Center Chulalongkorn Hospital, Thai Red Cross Society said that the Thai Red Cross There are preparations to deal with emerging diseases and there are various measures to support, such as bed expansion by adding both internal and external beds, adding ICU beds to both the main hospital and the field hospital. Through the color separation of patients well in order to distribute them into places that can be cared for. and quality control

“The treatment Currently, there are many preventative and pain relievers. The new drug in the study was the monoclonal antibody drug class. that binds the created protein to the part of the virus not enter human cells Therefore, the virus cannot injure cells. There are several drugs in this group and their use is at the stage of infection. It is not recommended to use it in a period that is late or past 10 days because it is a phase of stimulating the immune system of the body.” Asst.Prof.Dr. Opas say

However, we will have to live with covid forever. What we have to do is to make the immunity in the community high enough. Can’t give people anything But injections and vaccination may not have a good response, for example, patients take immunosuppressive drugs or some people cannot take them.VaccineYes, what makes this gap narrow is the use of drugs, both oral and injectable drugs. The use of monoclonal antibodies is a good way to reduce the gap. Helps both treat and prevent like the flu This group of drugs are similar as well.